Skip to content

Clinical trials

Completed Primary Myelofibrosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Status: Completed Country / region: Italy Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20054
20075
20081
20091
20102
20114
20134
20142
20152
20161
20176
20181
20192
20202
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Celgene4
AbbVie3
European Organisation for Research and Treatment of Cancer - EORTC3
Icahn School of Medicine at Mount Sinai3
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS2
Fondazione IRCCS Policlinico San Matteo di Pavia2
Gruppo Italiano Trapianto di Midollo Osseo2
Hoffmann-La Roche2
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis44
Polycythemia Vera15
Thrombocythemia, Essential14
Myeloproliferative Disorders13
Leukemia, Myeloid, Acute6
Neoplasms6
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Anemia4
Blast Crisis4
Burkitt Lymphoma4

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.